Last Updated: May 11, 2026

Drug Price Trends for NDC 00173-0859

✉ Email this page to a colleague

« Back to Dashboard

Average Pharmacy Cost for 00173-0859

Subscribe to access the full database, or Start Trial
Drug Name	NDC	Price/Unit ($)	Unit	Date
BREO ELLIPTA 100-25 MCG INHALR	00173-0859-14	5.36628	EACH	2026-04-22
BREO ELLIPTA 100-25 MCG INHALR	00173-0859-10	6.50314	EACH	2026-04-22
BREO ELLIPTA 100-25 MCG INHALR	00173-0859-14	5.36546	EACH	2026-03-18
BREO ELLIPTA 100-25 MCG INHALR	00173-0859-10	6.50380	EACH	2026-03-18
BREO ELLIPTA 100-25 MCG INHALR	00173-0859-14	5.36901	EACH	2026-02-18
>Drug Name	>NDC	>Price/Unit ($)	>Unit	>Date

Best Wholesale Price for NDC 00173-0859

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions

Subscribe to access the full database, or Start Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Dates	Price Type
BREO ELLIPTA INHALER 100/25MCG	GlaxoSmithKline	00173-0859-10	1	360.34	360.34000	2022-08-01 - 2027-07-31	FSS
BREO ELLIPTA INHALER 100/25MCG	GlaxoSmithKline	00173-0859-10	1	280.16	280.16000	2023-01-01 - 2027-07-31	Big4
BREO ELLIPTA INHALER 100/25MCG	GlaxoSmithKline	00173-0859-10	1	362.81	362.81000	2023-01-01 - 2027-07-31	FSS
BREO ELLIPTA INHALER 100/25MCG	GlaxoSmithKline	00173-0859-10	1	288.99	288.99000	2024-01-01 - 2027-07-31	Big4
BREO ELLIPTA INHALER 100/25MCG	GlaxoSmithKline	00173-0859-10	1	373.70	373.70000	2024-01-01 - 2027-07-31	FSS
>Drug Name	>Vendor	>NDC	>Count	>Price ($)	>Price/Unit ($)	>Dates	>Price Type

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.